Six Area, Six Sign Atopic Dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis*
- 1 September 1996
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 135 (s48) , 25-30
- https://doi.org/10.1111/j.1365-2133.1996.tb00706.x
Abstract
The Six Area, Six Sign Atopic Dermatitis severity score has proved to be a simple and effective system for recording and monitoring disease activity in atopic dermatitis. The score is obtained by grading six signs (erythema, exudation, excoriation, dryness, cracking and lichenification), each on a scale of () (absent), 1 (mild), 2 (moderate), or 3 (severe), at each of six sites; arms, hands, legs, feet, head and neck, trunk. The maximum score is 108.Keywords
This publication has 13 references indexed in Scilit:
- The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical useBritish Journal of Dermatology, 2010
- Cyclosporine in severe childhood atopic dermatitis: A multicenter studyJournal of the American Academy of Dermatology, 1996
- Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitisThe Lancet, 1996
- Novel cycle changes in scalp hair are caused by etretinate therapyBritish Journal of Dermatology, 1995
- Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapyBritish Journal of Dermatology, 1995
- Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trialBritish Journal of Dermatology, 1993
- Severity Scoring of Atopic Dermatitis: The SCORAD IndexDermatology, 1993
- A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczemaBritish Journal of Dermatology, 1992
- Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitisThe Lancet, 1991
- Failure of papaverine to reduce pruritus in atopic dermatitis: a double-blind, placebo-controlled cross-over studyBritish Journal of Dermatology, 1990